Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Juli 2019 08:00 ET | Quelle: Lutronic Vision, Inc.

Lutronic Vision to Present R:GEN™ Efficacy Data at 19th EURETINA Congress

- Presentation to highlight results of R:GEN™ laser treatment from a clinical trial in patients with Central Serous Chorioretinopathy - BILLERICA, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Lutronic...
17. Juni 2019 17:00 ET | Quelle: Lutronic Vision, Inc.

Lutronic Vision’s R:GEN™ Treats First CSC Patient at Seoul National University Hospital

BILLERICA, Mass., June 17, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or the “Company”), a wholly-owned subsidiary of Lutronic Corporation, today announced that its R:GEN™ retina treatment...
26. März 2019 17:00 ET | Quelle: Lutronic Vision, Inc.

Lutronic Vision Engages World Renowned Retina Expert for R:GEN™ Pilot AMD Clinical Study

BILLERICA, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or “the Company”), a wholly-owned subsidiary of Lutronic Corporation, today announced that it has signed a memorandum...
29. Januar 2019 15:30 ET | Quelle: Lutronic Vision, Inc.

Lutronic Vision Initiates Preclinical Trial of R:GEN™ Laser for the Treatment of Dry AMD

BILLERICA, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision, a wholly-owned subsidiary of Lutronic Corporation, announced today that it has initiated a preclinical trial to determine the...